查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386206

全球德国麻疹疫苗市场：趋势、预测、竞争分析（~2030 年）

Rubella Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

德国麻疹疫苗趋势与预测

预计到2030年，全球德国麻疹疫苗市场规模将达到约2.45亿美元，2024年至2030年年复合成长率为4.1%。该市场的主要驱动力是新兴国家对组合疫苗的需求不断增长以及德国麻疹疫苗接种计划的采用率不断上升。全球德国麻疹疫苗市场未来性广阔，医院、非政府组织和小儿科诊所市场充满机会。

德国麻疹疫苗市场洞察

Lucintel 预测，麻疹-德国麻疹疫苗越来越多地用于预防麻疹和德国德国麻疹等两种高度传染性疾病，预计在预测期内将出现最高增长。

由于疫苗接种率高且该地区有主要製造商，预计北美将在预测期内实现最高成长。

市场规模/估计：以金额的德国麻疹疫苗市场规模估计（百万美元）

趋势和预测分析：各细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）

細項分析：按类型、最终用途和地区按金额估算德国麻疹疫苗市场规模（百万美元）

区域分析：北美、欧洲、亚太地区和世界其他地区德国麻疹疫苗市场细分

成长机会：德国麻疹疫苗市场按类型、最终用途和地区分類的成长机会分析

策略分析：德国麻疹疫苗市场併购、新产品开发、竞争形势等

基于波特五力模型的产业竞争实力分析

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球德国麻疹疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球德国麻疹疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球德国麻疹疫苗市场：按类型
    • 单价製剂
    • 麻疹德国麻疹疫苗
    • 麻疹、腮腺炎和德国麻疹疫苗
    • 麻疹、腮腺炎、德国麻疹水痘疫苗
  • 全球德国麻疹疫苗市场：依最终用途分类
    • 医院
    • NGO
    • 小儿科诊所
    • 其他的

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球德国麻疹疫苗市场：按地区
  • 北美德国麻疹疫苗市场
  • 欧洲德国麻疹疫苗市场
  • 亚太地区德国麻疹疫苗市场
  • 其他地区风疹德国麻疹市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球德国麻疹疫苗市场成长机会
    • 全球德国麻疹疫苗市场成长机会（依最终用途）
    • 全球德国麻疹疫苗市场成长机会（按地区）
  • 全球德国麻疹疫苗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球德国麻疹疫苗市场产能
    • 全球德国麻疹疫苗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • MedImmune
  • China National Biotec
  • GlaxoSmithKline
  • Pfizer
简介目录

Rubella Vaccine Trends and Forecast

The future of the global rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets. The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

A more than 150-page report is developed to help in your business decisions.

Rubella Vaccine by Segment

The study includes a forecast for the global rubella vaccine by type, end use, and region.

Rubella Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Formulation
  • Measles-Rubella Vaccine
  • Measles, Mumps, Rubella Vaccine
  • Measles Mumps Rubella Varicella Vaccine

Rubella Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • NGO'S
  • Pediatric Clinics
  • Others

Rubella Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rubella Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rubella vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rubella vaccine companies profiled in this report include-

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • Medimmune
  • China National Biotec
  • Glaxosmithkline
  • Pfizer

Rubella Vaccine Market Insights

Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Features of the Global Rubella Vaccine Market

Market Size Estimates: Rubella vaccine market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rubella vaccine market size by type, end use, and region in terms of value ($M).

Regional Analysis: Rubella vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rubella vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rubella vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rubella vaccine market size?

Answer: The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030.

Q.2 What is the growth forecast for rubella vaccine market?

Answer: The global rubella vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rubella vaccine market?

Answer: The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

Q4. What are the major segments for rubella vaccine market?

Answer: The future of the rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets.

Q5. Who are the key rubella vaccine market companies?

Answer: Some of the key rubella vaccine companies are as follows:

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • Medimmune
  • China National Biotec
  • Glaxosmithkline
  • Pfizer

Q6. Which rubella vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

Q7. In rubella vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rubella vaccine market by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine), end use (hospitals, NGO's, pediatric clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rubella Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rubella Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rubella Vaccine Market by Type
    • 3.3.1: Monovalent Formulation
    • 3.3.2: Measles-Rubella Vaccine
    • 3.3.3: Measles, Mumps, Rubella Vaccine
    • 3.3.4: Measles Mumps Rubella Varicella Vaccine
  • 3.4: Global Rubella Vaccine Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: NGO's
    • 3.4.3: Pediatric Clinics
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rubella Vaccine Market by Region
  • 4.2: North American Rubella Vaccine Market
    • 4.2.2: North American Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.3: European Rubella Vaccine Market
    • 4.3.1: European Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.3.2: European Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.4: APAC Rubella Vaccine Market
    • 4.4.1: APAC Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.4.2: APAC Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.5: ROW Rubella Vaccine Market
    • 4.5.1: ROW Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.5.2: ROW Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rubella Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Rubella Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Rubella Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Rubella Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rubella Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rubella Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Johnson & Johnson
  • 7.2: Sanofi Pasteur
  • 7.3: Bavarian Nordic
  • 7.4: MedImmune
  • 7.5: China National Biotec
  • 7.6: GlaxoSmithKline
  • 7.7: Pfizer